Morrison Foerster advised REPKON USA Holdings Inc. on the deal. REPKON USA Holdings Inc., a technology leader in the aerospace and defense market, announced its definitive...
REPKON’s Acquisition of McCormick Stevenson Corporation
CSPC Megalith Biopharmaceutical’s License Agreement with Elevation Oncology
Morrison Foerster advised CSPC Megalith Biopharmaceutical Co. on the deal. CSPC Megalith Biopharmaceutical Co., Ltd., a subsidiary of CSPC Pharmaceutical Group Limited (Stock code: 1093.HK) announced an...
Dr. Reddy’s’ Acquisition of Eton Pharmaceuticals
Morrison Foerster advised Eton Pharmaceuticals on the deal. Eton Pharmaceuticals (NASDAQ: ETON) announced its asset sale of several of its branded and generic injectable products to Dr....